Lpath Inc (LPTN.OQ) Quote| Reuters.com
Edition:
United States

Lpath Inc (LPTN.OQ)

LPTN.OQ on NASDAQ Stock Exchange Capital Market

2.05USD
27 Jun 2016
Change (% chg)

$-0.13 (-5.96%)
Prev Close
$2.18
Open
$2.13
Day's High
$2.14
Day's Low
$1.99
Volume
22,473
Avg. Vol
20,553
52-wk High
$5.88
52-wk Low
$1.81

LPTN.OQ

Chart for LPTN.OQ

About

Lpath, Inc. is a biotechnology company. The Company is focused on the discovery and development of lipidomic-based therapeutic antibodies. The Company's product candidates include iSONEP, ASONEP and Lpathomab. The Company utilizes ImmuneY2 technology for the production of its antibodies. iSONEP is the ocular formulation of... (more)
No analyst recommendations are available for LPTN.OQ.

Overall

Beta: 0.52
Market Cap(Mil.): $5.15
Shares Outstanding(Mil.): 2.36
Dividend: --
Yield (%): --

Financials

  LPTN.OQ Industry Sector
P/E (TTM): -- 38.82 34.11
EPS (TTM): -4.67 -- --
ROI: -80.80 -5.72 14.23
ROE: -83.08 -4.83 15.46

BRIEF-Lpath awarded department of defense grant

* Lpath awarded department of defense grant for traumatic brain injury pain study

Jun 20 2016

BRIEF-Lpath announces 1-for-14 reverse stock split

* Number of common shares outstanding will be decreased from approximately 33.1 million pre-split to 2.36 million shares post-split

Jun 09 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$25.00
Provider : Wright Reports
$75.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.